Auxilius Analysis: $10M Raised
What is Auxilius?
Auxilius provides an integrated platform for automating R&D accruals, budgeting, and financial planning specifically for biopharma companies. The platform is designed to enhance accuracy in clinical trial financial management and is trusted by over 90 biopharmas and their auditors. Auxilius offers features such as dynamic forecasting, investigator spend intelligence, and close automation to streamline financial processes.
Employees
11-50
Founded
2020
Industry
FinTech, SaaS, HealthTech
Latest Funding Amount
$10,000,000
Latest Funding Round Size
$10.0M
Product Features & Capabilities
- Clinical and CMC accruals
- Investigator spend intelligence
- Investigator payments reconciliation
- Close automation
- Dynamic forecasting
Use Cases
Automate accruals for clinical trials; Validate site payment accuracy with 90% match rate; Manage change orders and protocol amendments; Provide real-time expense estimates; Streamline collaboration between clinical operations and finance
How much Auxilius raised
Funding Round - $10.0M
RecentOther Considerations
Trusted by over 90 biopharmas; SOC 1 and SOC 2 compliant; Provides dedicated support from a team of CPAs and finance professionals
Gtm Strategy
Auxilius employs a hybrid go-to-market (GTM) strategy that combines elements of both product-led growth (PLG) and sales-led approaches.
Upon analyzing the Auxilius website, it is evident that the company emphasizes a demo booking system for potential customers to experience the platform firsthand, which aligns with a sales-led approach. The absence of explicit pricing information suggests that pricing details are likely provided during the demo or consultation process, indicating a more traditional sales cycle. However, the presence of educational resources, including a training library with over 90 user guides, supports self-service learning, a hallmark of product-led growth. Customer testimonials highlight the platform's effectiveness in streamlining financial processes, suggesting that existing users find value in the product, which is essential for viral adoption. Overall, Auxilius's strategy reflects a balance between facilitating user access through demos and providing educational resources, catering to both self-service and high-touch customer engagement.
Upon analyzing the Auxilius website, it is evident that the company emphasizes a demo booking system for potential customers to experience the platform firsthand, which aligns with a sales-led approach. The absence of explicit pricing information suggests that pricing details are likely provided during the demo or consultation process, indicating a more traditional sales cycle. However, the presence of educational resources, including a training library with over 90 user guides, supports self-service learning, a hallmark of product-led growth. Customer testimonials highlight the platform's effectiveness in streamlining financial processes, suggesting that existing users find value in the product, which is essential for viral adoption. Overall, Auxilius's strategy reflects a balance between facilitating user access through demos and providing educational resources, catering to both self-service and high-touch customer engagement.
Reported Clients
Auxilius has reported several notable clients on their website, including Dynavax, Fractyl Health, TG Therapeutics, Abcuro, and PMV Pharma. These clients have provided positive feedback regarding the impact of Auxilius on their financial management processes. For instance, David Chen from Dynavax emphasized the tool's ability to integrate various types of information, enhancing their forecasting methodology. Dean Hotaling from Fractyl Health highlighted the real-time organization and significant efficiency improvements they experienced using Auxilius.
